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Metanephric  adenoma  (AM)  is  a benign  renal  tumour  representing  0.2%  of  all  renal  tumours
[1].  It  is  both  clinically  and  radiologically  difﬁcult  to  differentiate  from  renal  carcinoma,
often  resulting  in  unnecessary  surgery.  We  report  herein  the  magnetic  resonance  (MR)
imaging  features  of  a  MA  incidentally  discovered  in  a  50-year-old  man  and  subsequently
histopathologically  conﬁrmed.
Case report
A  50-year-old  man  with  prior  history  of  surgically-repaired  right  inguinal  hernia,  arterial
hypertension  and  chronic  obstructive  bronchitis  underwent  chest  computed  tomography
(CT)  examination  because  of  a  clinical  worsening  of  his  pulmonary  status.  CT  examination
incidentally  revealed  the  presence  of  a  soft  tissue  lesion  at  the  inferior  aspect  of  the  left
kidney.  Before  intravenous  administration  of  iodinated  contrast  material,  the  renal  lesion
was  isoattenuating  relative  to  the  adjacent  renal  parenchyma  (35  HU),  deforming  the  out-
line  of  the  kidney.  No  calciﬁcations  or  pyelocalyceal  cavity  involvement  were  observed.
After  intravenous  administration  of  iodinated  contrast  material,  the  lesion  appeared  as  a
rounded  and  well-demarcated  mass,  measuring  32  ×  27  mm  on  its  two  largest  axial  perpen-
dicular  diameters.  Contrast  enhancement  was  moderate  and  gradual,  with  an  attenuation
value  of  51  HU  during  the  early  phase  and  79  HU  during  the  late  phase  following  injection.
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he  lesion  remained  hypoattenuating  relative  to  the  adja-
ent  renal  parenchyma.  MR  imaging  examination  was
erformed  before  renal  biopsy  and  showed  a  homogeneous
esion  at  the  inferior  aspect  of  the  left  kidney,  which  was
lightly  hypointense  on  T1-weighted  MR  images  by  compari-
on  to  the  adjacent  renal  parenchyma.  A  small  hyperintense
rea  was  observed  on  fat-saturated  T1-weighted  MR  images
uggestive  of  bleeding  (Fig.  1).  On  T2-weighted  MR  images,
he  lesion  was  mildly  hyperintense  with  a  peripheral
ypointense  rim  (Fig.  2).  The  renal  lesion  was  markedly
yperintense  on  the  diffusion-weighted  MR  sequence  (Fig.  3)
nd  had  an  apparent  diffusion  coefﬁcient  (ADC)  of
.62  ×  10−3 mm2/s  (b  =  50  and  800  s/mm2).  After  intravenous
dministration  of  10  ml  of  a  gadolinium  chelate  (gadoterate
eglumine,  Dotarem®,  Guerbet,  Roissy-Charles-de-Gaulle,
rance),  the  lesion  showed  a  slow  and  gradual  contrast
nhancement  and  remained  hypointense  by  comparison  with
he  adjacent  renal  parenchyma  (Fig.  4).  Histopathological
igure 1. Fat-saturated T1-weighted (TR/TE = 3.41/1.5 ms)
radient-echo MR sequence (3D VIBE) shows a lesion of the left
idney displaying mild signal hypointensity by comparison with the
djacent renal parenchyma, that contains a small hyperintense area
orresponding to intra-tumoral bleeding (arrow).
igure 2. T2-weighted (TR/TE = 3000/130 ms) turbo spin-echo
TSE) MR image in the coronal plane. The renal tumour (arrow)
s mildly hyperintense with a peripheral hypointense rim (arrow-
eads).
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nalysis  of  the  renal  tissues  obtained  with  percutaneous
iopsy  revealed  a  tubulo-papillary  proliferation  made  up  of
egular  cubo-cylindrical  cells  with  a  monotonous  appearance
nd  large  nuclei  occupying  almost  the  entire  cytoplasm.
o  mitoses  were  visible  (Fig.  5).  The  immunohistochemical
tudy  revealed  that  the  cell  expression  proﬁle  was  CK7—,
504+  (weak  and  focal),  EMA—  and  Wt1  ++.  The  histological
ppearance  deﬁnitely  conﬁrmed  the  diagnosis  of  MA.
iscussion
A  is  a  rare  tumour  that  is  more  common  in  women  (2:1  sex-
atio)  and  arises  at  a  mean  age  of  46.8  years  [1,2].  However,
ases  of  MA  have  been  reported  in  children  [3].
These  tumours  generally  have  a  benign  course  but  lymph
ode  metastases  have  been  described  [4].  As  was  the  case
ith  our  patient,  50%  of  these  tumours  are  discovered  inci-
entally  [1]. The  most  commonly  accompanying  symptoms
re  hematuria,  low  back  pain  or  a  palpable  renal  mass.  In
2%  of  patients,  MA  is  associated  with  polycythaemia  [1].  A
ingle  lesion  is  most  common  although  exceptional  cases  of
ultifocal  or  bilateral  MA  have  been  published  in  the  litera-
ure  [5]. On  average,  these  tumours  measure  3.6  cm  (range:
.5—8  cm)  [2].
MA  appears  as  a well-deﬁned  lesion  on  imaging  [2,6,7].
n  ultrasonography,  MA  is  most  often  hyperechoic  but  can
lso  be  iso-  and  even  hypoechoic  [2].  Duplex  Doppler  ultra-
onography  demonstrates  hypovascularisation  of  the  lesion
2].  Contrast-enhanced  ultrasonography  has  not  established
apabilities  to  clearly  differentiate  MA  from  a  malignant
enal  tumour  [6].
On  CT  images,  MA  appears  as  a  hyper-  or  isoattenuating
ass  with  only  mild  contrast  enhancement  [2]. Calciﬁcations
ay  also  be  present  [2,6].
MR  imaging  is  currently  considered  as  the  gold-standard
xamination  for  the  characterisation  of  renal  masses  [8].  On
R  imaging,  MA  typically  appears  as  an  iso-  or  hypointense
ass  on  T1-weighted  sequences  and  slightly  hyperintense
n  T2-weighted  sequences,  as  was  the  case  here  [6].
igure 3. Diffusion-weighted MR image (1.5 Tesla, single-shot
cho-planar, TR/TE = 3900 ms/91 ms;  b = 800 s/mm2) in the axial
lane. The lesion (arrow) is markedly hyperintense.
MRI  features  of  metanephric  adenoma  389
Figure 4. T1-weighted (TR/TE = 3.41/1.5 ms) gradient-echo (3D VIBE) MR image in the axial plane obtained after injection of gadolinium
chelate. a: during the arterial phase (30 seconds), the renal lesion shows slight contrast enhancement (arrow) and is hypointense by
comparison with the adjacent renal parenchyma; b: during the delayed p
less intense enhancement than the adjacent renal parenchyma (arrow).
Figure 5. Histopathological examination of the renal lesion shows
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Pathol 1995;19:1101—14.a tubulo-papillary tumour proliferation made up of regular cubo-
cylindrical cells (HES staining, × 100 magniﬁcation).
Nonetheless,  several  cases  of  hypointense  MA  on  both
T1-  and  T2-weighted  MR  images  have  been  reported  [2].
Hypointensity  are  due  to  the  presence  of  calciﬁcations  in  2/3
of  cases  [2].  Several  studies  have  demonstrated  the  utility
of  diffusion-weighted  MR  imaging  for  the  characterisation
of  focal  renal  lesions.  Calculation  of  the  apparent  diffusion
coefﬁcient  (ADC)  helps  better  characterize  renal  lesions.  In
this  regard,  renal  tumours  have  a  signiﬁcantly  lower  mean
ADC  value  than  normal  renal  parenchyma  [9,10],  and  malig-
nant  tumours  have  a  signiﬁcantly  lower  mean  ADC  value
than  benign  renal  tumours  [10].  These  data  were  conﬁrmed
in  a  recent  meta-analysis  of  17  studies  and  764  patients,
since  renal  carcinomas  were  found  to  have  a  mean  ADC
of  1.61  ±  0.08  ×  10−3 mm2/s  vs.  2.1  ±  0.09  ×  10−3 mm2/s
for  benign  tumours  (P  <  0.0001)  [10].  In  our  patient,  the
tumour  had  an  ADC  of  1.62  ×  10−3 mm2/s.  However,  the  dis-
criminatory  potential  of  ADC  and  the  b  values  to  be  used
to  optimise  differentiation  have  yet  to  be  clearly  estab-
lished.  After  injection  of  a  gadolinium  chelate,  the  lesion
remains  hypointense  by  comparison  to  the  adjacent  renal
parenchyma,  conﬁrming  the  hypervascular  nature  of  the
tumour  [2].
Treatment  of  MA  has  not  been  widely  discussed,  although
some  authors  recommend  simple  surveillance  after  thehase (2 minutes), the lesion is heterogeneous with almost total but
iagnosis  has  been  conﬁrmed.  For  example,  Wang  et  al.
eported  7  cases  of  MA  followed-up  but  not  otherwise
reated  after  diagnosis:  neither  recurrence  nor  local  metas-
asis  was  observed  after  a  follow-up  period  ranging  from  7
o  57  months  [11].  However,  most  authors  recommend  an
nitial  partial  nephrectomy  followed  by  surveillance  [2,7],
specially  since  a  minimally  invasive  surgical  technique  can
e  used  [12],  because  of  the  risk  of  lymph  node  or  bone
etastases  [4]. The  contribution  of  a biopsy  and  immunohis-
ochemical  analysis  has  been  studied  in  certain  cases  [13].
he  immunohistochemical  proﬁle  of  MA  is  typically  EMA—,
T1+,  CD57  ++  and  CK7±. Immunohistochemical  analysis
onﬁrms  the  diagnosis  in  the  majority  of  cases  and,  most
mportantly,  rules  out  renal  carcinoma  [13]. This  stresses  the
mportance  of  biopsy  in  the  overall  management  of  small
enal  masses.  Once  diagnosed,  benign  renal  tumours  can
e  removed  using  a  tumour  resection  sparing  the  surround-
ng  renal  parenchyma  [7,13].  In  addition,  few  complications
ave  been  reported  with  renal  tumour  biopsies  and  no  cases
f  tumoral  seeding  along  the  needle  tract  have  been  pub-
ished  [13].
In  conclusion,  the  imaging  features  of  MA  are  not  speciﬁc
nd  do  not  allow  the  presence  of  malignant  disease  to  be
ntirely  ruled  out.  The  possible  uses  of  diffusion-weighted
R  imaging  to  differentiate  between  MA  and  other  renal
umours  and  especially  from  malignant  disease  have  yet  to
e  fully  explored.  MA  has  a  well-established  immunohisto-
hemical  proﬁle,  which  conﬁrms  the  diagnosis.  The  use  of
ercutaneous  biopsy  is  therefore  recommended  in  order  to
etermine  the  best  therapeutic  option.
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